---
schema_version: "secwatch.filing_event.v1"
accession: "0001759425-25-000034"
form_type: "8-K"
ticker: "MIRM"
cik: "0001759425"
company_name: "Mirum Pharmaceuticals, Inc."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:35:27.809838+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Mirum Pharmaceuticals 2025 Annual Meeting results: three directors elected

## Summary
- Class III directors elected: Laura Brege (17.97M for, 18.17M withheld), Michael Grey (30.78M for), Christopher Peetz (35.98M for).
- Ratified Ernst & Young as independent auditor for FY2025: 43.12M for, 19.2K against, 19.4K abstentions.
- Advisory vote on executive compensation approved: 34.67M for, 1.46M against, 8.9K abstentions.
- Broker non-votes of 7.02M on director elections and compensation proposals.

## SEC filing metadata
- accession: 0001759425-25-000034
- form_type: 8-K
- ticker: MIRM
- cik: 0001759425
- company_name: Mirum Pharmaceuticals, Inc.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759425/000175942525000034/0001759425-25-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759425/000175942525000034/mirm-20250529.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001759425-25-000034
- JSON: https://secwatch.observer/filing/0001759425-25-000034.json
- Plain text: https://secwatch.observer/filing/0001759425-25-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.